HyperglycemiaHypoglycemiaBlood GlucoseMortalityInsulinHypoglycemic AgentsGlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1GlucagonDiabetes Mellitus, Type 2HyperinsulinismDiabetes MellitusHospital MortalityHemoglobin A, GlycosylatedGlucose Clamp TechniqueStreptozocinGlucose Tolerance TestEpinephrineTime FactorsInfant MortalityIslets of LangerhansC-PeptideBlood Glucose Self-MonitoringInsulin Infusion SystemsPancreatic PolypeptideFastingInsulin, Long-ActingGluconeogenesisCause of DeathRetrospective StudiesPostprandial PeriodDiabetes ComplicationsInsulin ResistanceInsulin-Secreting CellsTreatment OutcomeDiabetic AngiopathiesGlucokinaseCohort StudiesRisk FactorsInfant, NewbornCritical IllnessGlycosuriaProspective StudiesInsulin ComaPregnancy in DiabeticsClinical AlarmsLiverDiabetic KetoacidosisPhlorhizinFollow-Up StudiesSulfonylurea CompoundsRats, Sprague-DawleyChild MortalityBody WeightGlucagon-Like Peptide 1HydrocortisoneFatty Acids, NonesterifiedMaternal MortalityGlucose IntolerancePancreasDisease Models, AnimalCardiovascular DiseasesDiabetic NephropathiesGlipizidePancreas, ArtificialVentromedial Hypothalamic NucleusHomeostasisAcute DiseaseInsulinomaRats, WistarInfusions, IntravenousAge FactorsReference ValuesProportional Hazards ModelsRisk AssessmentMice, Inbred C57BLNesidioblastosisObesityIncidencePancreatectomyMetforminCongenital HyperinsulinismPregnancyHyperglycemic Hyperosmolar Nonketotic ComaDiabetic NeuropathiesDiazoxide3-Hydroxybutyric AcidSurvival AnalysisSurvival RateNorepinephrineAcarboseOxidative StressPrognosisDipeptidyl-Peptidase IV InhibitorsLactic AcidDiabetic ComaGlycogenLactatesGlucagon-Secreting Cells